Literature DB >> 16937040

[Influence of technical advancements on the management of biliary tract diseases].

Andreas Püspök1.   

Abstract

Modern cross sectional imaging methods like CT and MRCP have replaced more invasive methods for the diagnosis of cholangiolithiasis as well as benign and malignant biliary strictures. Only if a histologic or cytologic confirmation of the diagnosis is necessary, is a direct access to the biliary tract either with ERC or PTC justified as a diagnostic procedure. Due to technical advancements in laparoscopic surgery intraoperative bile duct revision has become a standard procedure for patients with choledocholithiasis discovered during cholecystectomy. It has been shown to be equally effective to ERC. In this setting ERC therefore has lost its unique claim for the treatment of bile duct stones, while it remains the treatment of choice in patients with prior cholecystectomy. In contrast ERC, sometimes in combination with PTC, has become the mainstay in the treatment of biliary lesions like leakage and benign strictures. The same is true for the palliation of malignant biliary strictures. Surgery should be reserved for patients in whom minimal invasive methods fail and for the curative treatment of malignant lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16937040     DOI: 10.1007/s10354-006-0313-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  30 in total

Review 1.  Preoperative imaging of biliary tract cancers.

Authors:  Janio Szklaruk; Eric Tamm; Chusilp Charnsangavej
Journal:  Surg Oncol Clin N Am       Date:  2002-10       Impact factor: 3.495

2.  Laparoscopic common bile duct exploration and cholecystectomy versus endoscopic stone extraction and laparoscopic cholecystectomy for choledocholithiasis. A prospective randomized study.

Authors:  G Sgourakis; K Karaliotas
Journal:  Minerva Chir       Date:  2002-08       Impact factor: 1.000

Review 3.  [Interventions for benign biliary strictures].

Authors:  A Lubienski; M Duex; K Lubienski; J Blietz; G W Kauffmann; T Helmberger
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

Review 4.  Sclerosing cholangitis.

Authors:  George R MacFaul; Roger W Chapman
Journal:  Curr Opin Gastroenterol       Date:  2005-05       Impact factor: 3.287

5.  Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones.

Authors:  M Rhodes; L Sussman; L Cohen; M P Lewis
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

6.  Impact of endoscopic intervention in 100 patients with suspected postcholecystectomy bile leak.

Authors:  Arthur John Kaffes; Luke Hourigan; Nicolas De Luca; Karen Byth; Stephen John Williams; Michael John Bourke
Journal:  Gastrointest Endosc       Date:  2005-02       Impact factor: 9.427

7.  Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.

Authors:  Thomas Zoepf; Ralf Jakobs; Joachim C Arnold; Darius Apel; Jürgen F Riemann
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

8.  Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography.

Authors:  Shintaro Kondo; Hiroyuki Isayama; Masaaki Akahane; Nobuo Toda; Naoki Sasahira; Yosuke Nakai; Natsuyo Yamamoto; Kenji Hirano; Yutaka Komatsu; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Kuni Ohtomo; Masao Omata
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

9.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.

Authors:  M Kaya; B T Petersen; P Angulo; T H Baron; J C Andrews; C J Gostout; K D Lindor
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

10.  Value of brush cytology for dominant strictures in primary sclerosing cholangitis.

Authors:  C Y Ponsioen; S M Vrouenraets; A W van Milligen de Wit; P Sturm; M Tascilar; G J Offerhaus; M Prins; K Huibregtse; G N Tytgat
Journal:  Endoscopy       Date:  1999-05       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.